Fritextsökning
Artiklar per år
Innehållstyper
-
Han är Tegnells ersättare
Anders Tegnell lämnar Folkhälsomyndigheten på måndag nästa vecka. Näste man att stiga in som statsepidemiolog blir Anders Lindblom.
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, about 90 patients in Sweden have now been treated with this method. “Almost half of them have become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.
-
Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages
For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridiculed by the medical establishment. However, from our perspective today, we can sum it up with the saying: He who laughs last laughs best, writes Samuel Lagercrantz in an editorial.
-
Björn Arvidsson: ”We need to change perspective”
If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network will generate as many versions as the people you ask. Most likely, we will miss many opportunities with our lack of communication, writes Björn Arvidsson in a column.
-
A new international stem cell research centre has been created in Copenhagen
A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will advance new medical technology and new stem cell therapies.
-
Företag, fackförbund och myndigheter gör gemensam sak för att hjälpa Ukraina
Arjo stoppar leveranser till Ryssland och skänker sjukhussängar till Ukraina. Bactiguard skänker intensivvårdsutrustning till landet och Novartis ger 3 miljoner amerikanska dollar. Det är några exempel på hur branschen sluter upp bakom den ukrainska folket.
-
Ny modell ger ytterligare stöd för munskydd: ”Ger ett utmärkt skydd”
Forskare vid bland annat Chalmers har tagit fram en modell för att mäta hur virus färdas genom luften – och hur effektivt munskydd är för att hindra smittspridning. Deras slutsats: rätt munskydd, buret på rätt sätt, ger ett utmärkt skydd.
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure that new medicines will be available for all citizens in Europe, writes Marie Gårdmark in a column.
-
Lundbeck behind the first EU-approved intravenous migraine treatment
A preventive, intravenous treatment for migraines has been approved in the EU for the first time.
-
Life Science Sweden´s international issue is on its way
A new issue of Life Science Sweden is on its way to print, packed with news, interviews and reports.
-
Study: An objective diagnosis of constant tinnitus may be possible
A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tinnitus, which was demonstrated in a study made by researchers at the Karolinska Institute.
-
“Together Stockholm-Uppsala and Medicon Valley can make Scandinavia a leading life science region”
“Denmark, Sweden, Norway and Finland all have national life science strategies, but the Swedish strategy is the only one explicitly emphasizing the Nordic dimension. But what if the leading life science nations, Denmark and Sweden, joined forces, took the lead and pioneered Nordic life science collaboration? Wouldn´t we then be able to "bake a bigger cake?", writes Anette Steenberg and Ulf G. Andersson in a debate article.
-
Stockholm aims at becoming one of the world’s top life science regions
Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 2025. One step on the way to achieve this is by hosting a world-leading congress in medtech.
-
The route to vaccines for everyone: “We did not just sit around and wait”
The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a proposal, and Richard Bergström did not hesitate. “I already had a notion that this would work,” he says in an interview with Life Science Sweden.
-
Anna Törner: Success requires bold decisions!
“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.
-
Giulia Gaudenzi: Innovation for good
"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively – we need to engage bravely with the politics of poverty and scarcity. Even in life sciences", writes Giulia Gaudenzi in a column.
-
Långtidscovid hos barn och unga får definition
Brittiska forskare har tagit fram en definition av vad som ska räknas som långtidscovid hos barn och ungdomar – något som kan underlätta forskning kring tillståndet.
-
"Långtidscovid är en elefant i rummet"
Intresset för att forska och lära sig mer om postcovid har varit märkligt svagt och ännu finns många kunskapsluckor kring diagnosen. Det menar Läkare till läkare, ett nätverk för läkare med covid-19 som arbetar för att ändra på det. – Det mest förvånande har faktiskt varit bristen på nyfikenhet, säger Lisa Norén, en av talespersonerna för gruppen.
-
Ny larmrapport: Över en miljon dör på grund av resistens mot antibiotika
En bra bit över en miljon dödsfall i världen orsakades av antibiotikaresistens under 2019, enligt en analys av globala data från 204 länder.
BREAKING